evans blue has been researched along with Hearing Loss in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X; Niu, H; Qiao, Y; Shi, X; Wang, C; Xu, K; Xu, Z; Zeng, L | 1 |
| Kastenbauer, S; Klein, M; Koedel, U; Pfister, HW | 1 |
2 other study(ies) available for evans blue and Hearing Loss
| Article | Year |
|---|---|
Observation of permeability of blood-labyrinth barrier during cytomegalovirus-induced hearing loss.
Topics: Animals; Animals, Newborn; Audiometry; Capillary Permeability; Cochlea; Coloring Agents; Cytomegalovirus Infections; Ear, Inner; Evans Blue; Evoked Potentials, Auditory, Brain Stem; Hearing Loss; Hemorrhage; Hyperemia; Mice; Mice, Inbred BALB C | 2014 |
Meningitis-associated hearing loss: protection by adjunctive antioxidant therapy.
Topics: Acetylcysteine; Animals; Anti-Bacterial Agents; Antioxidants; Audiometry; Ceftriaxone; Cell Count; Cochlea; Disease Models, Animal; Drug Interactions; Evans Blue; Evoked Potentials, Auditory, Brain Stem; Hearing Loss; Labyrinthitis; Male; Meningitis, Pneumococcal; Metalloporphyrins; Peroxynitrous Acid; Rats; Rats, Wistar; Spiral Ganglion; Time Factors | 2003 |